Results 101 to 110 of about 2,643,317 (205)

Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro. [PDF]

open access: yes, 2011
The success of Imatinib (IM) therapy in chronic myeloid leukemia (CML) is compromised by the development of IM resistance and by a limited IM effect on hematopoietic stem cells.
Carsten Bokemeyer   +40 more
core   +2 more sources

Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Neutrophils exhibit remarkable functional plasticity and play dual roles in tissue protection and disease progression. This review summarizes their key biological functions and highlights the shift from conventional broad‐spectrum interventions to neutrophil‐based drug delivery systems.
Yibing Zhang   +4 more
wiley   +1 more source

Ubiquitination and Deubiquitination: From Molecular Mechanisms to Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Ubiquitination and deubiquitination form a reversible regulatory network that controls protein stability, localization, interactions, chromatin association, and signaling. E3 ligases generate distinct ubiquitin signals; DUBs remove or remodel them; and ubiquitin‐binding proteins decode chain topology and cellular context.
Wanqing Liu   +5 more
wiley   +1 more source

Cutaneous Leiomyosarcoma of the Skin: An Updated Review of Epidemiology, Pathogenesis, and Management

open access: yesInternational Journal of Dermatology, Volume 65, Issue 11, Page 2232-2238, November 2026.
This review provides an update on the epidemiology, pathogenesis, and clinical/histologic features of cutaneous leiomyosarcoma. Prognostic factors (e.g., depth of tumor involvement, grade, etc.) that can facilitate risk stratification are also discussed, as are treatment approaches for this rare malignancy.
Tejas P. Joshi   +4 more
wiley   +1 more source

Atypical chronic myeloid leukemia with der(20)t(17;20)(q21;q13)

open access: yes, 1999
We present a case of atypical chronic myeloid leukemia that developed blastic transformation four months after initial presentation, with the blast cells showing multilineage antigen expression.
Ma, SK   +9 more
core   +1 more source

Chronic myeloid leukemia with involvement of membranous labyrinth

open access: yesLeukemia Research Reports
This case report explains an extraordinary presentation of chronic myeloid leukemia (CML) in a 39-year-old male with a T315I mutation, presenting with acute bilateral hearing loss and imbalance secondary to myeloid blast crisis.
Mobachir El Kettani   +4 more
doaj   +1 more source

Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers

open access: yesChemMedChem, Volume 21, Issue 20, 28 October 2026.
Natural products trigger ferroptosis through iron overload, glutathione depletion, glutathione peroxidase 4 inhibition, and reactive oxygen species accumulation, selectively targeting aggressive, and drug‐resistant cancers. Polyphenols, alkaloids and terpenoids emerge as promising multi‐target agents to overcome therapy resistance and improve future ...
Giorgio Antoniolli
wiley   +1 more source

A Case of Atypical Chronic Myeloid Leukemia with the JAK2V617F Mutation

open access: yesLaboratory Medicine Online, 2011
김주연·이세련·남명현·윤수영·임채승·이창규·김병수·조윤정·김영기·이갑노 Ju Yeon Kim, M.D., Se Ryeon Lee, M.D., Myung-Hyun Nam, M.D., Soo-Young Yoon, M.D., Chae Seung Lim, M.D., Chang Kyu Lee, M.D., Byung Soo Kim, M.D., Yunjung Cho, M.D., Young Kee Kim, M.D., Kap No Lee, M.D. 고려대학교 의과대학 진단검사의학교실, 내과학교실 Departments of Laboratory Medicine and Internal Medicine, Korea University College ...
Ju Yeon Kim   +9 more
openaire   +1 more source

Home - About - Disclaimer - Privacy